This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction) | MicrobiomeTrials
← Back to trials NCT07254455
CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction) Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-07Est. Completion: 2027-12
Enrollment target: 900 participantsOther microbiome trials you might be interested in Atrial Fibrillation (AF) Cardiac Arrhythmia Atrial Fibrillation Ablation BDNF Atrial Cardiomyopathy
trial fibrillation (AF) is the most common cardiac arrhythmia worldwide, and its prevalence continues to rise. AF is ass…
Dijon, France Est. completion Jul 2029
Vasoplegic Syndrome of Cardiac Surgery
Vasoplasmic syndrome in cardiac surgery is one of the major postoperative complications.This syndrome is characterized b…
Amiens, France Est. completion Aug 20, 2021
The goal of this observational study is to better understand the role of measuring troponin (a protein measured by a blo…
Edinburgh, United Kingdom Est. completion Sep 2026